Funded Tech Companies
Tisbury Pharmaceuticals
Wondering who backed Tisbury Pharmaceuticals? OrbiMed, Pontifax Fund and Clarus joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Tisbury Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Cummings Center 412G
Beverly, MA 01915
USA
Beverly, MA 01915
USA
Phone
Undisclosed
Email Address
Not Recorded
Company Background Information
Overview
Tisbury Pharmaceuticals, Inc. discovers, develops, and commercializes therapy to treat primary open angle glaucoma. The company's clinical candidate, R-801, accelerates flow via the trabecular meshwork via redox catalysis and K+-ATP (channel activation). The company was incorporated in 2017.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/17/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Sternberg
Company Investors
- OrbiMed (Nissim Darvish)
- Pontifax Fund
- Clarus (Emmett Cunningham)
- Healthcap Venture Capital (Marten Steen)
Browse more funded tech companies:
Tire Agent | Tisento Therapeutics
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs